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Objective : There are two established surgical treatment options for car-
otid artery stenosis. Carotid endarterectomy (CEA) has been accepted as 
a gold standard for surgical treatment while carotid artery stenting (CAS) 
has recently become an alternative option. Each treatment option has ad-
vantages and disadvantages for the treatment outcomes. We propose a 
protocol for selection of a proper surgical treatment option for carotid ar-
tery stenosis.
Materials and Methods : A total of 192 published articles on manage-
ment of carotid artery stenosis were reviewed. Preoperatively considerable 
factors which had been repeatedly noted in those articles for the 
risk/benefits of CEA or CAS were selected. According to those factors, a 
protocol with four categories was established.
Results : CEA or CAS is indicated when the patient has a symptomatic 
stenosis ≥ 50%, or when the patient has an asymptomatic stenosis ≥ 
80%. Each treatment option has absolute indications and favorable 
indications. Each absolute indication is scored with three points, and each 
favorable indication, one point. Based on the highest scores, a proper 
treatment option (CEA or CAS) is selected.
Conclusion : We have been treating patients according to this protocol 
and evaluating the outcomes of our protocol-based decision because this 
protocol might be helpful in assessment of risk/benefit for selection of a 
proper surgical treatment option in patients with carotid artery stenosis.
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INTRODUCTION
Currently, there are two surgical treatment options 
for carotid artery stenosis, carotid endarterectomy (CEA) 
and carotid artery stenting (CAS). CEA has long been 
established as the gold standard for treatment of se-
vere symptomatic carotid artery stenosis.6)9)18)23)29)32) As 
CAS has become an alternative treatment option, it is 
difficult to decide which treatment option, CEA or 
CAS, is appropriate for patients with carotid artery 
stenosis.5) Each procedure has its own risks.2)5)23)25)35)44) 
In addition, various factors, such as patients' factors 
or radiographic data, could be related to the risk for 
these preventive procedures and should be catego-
rized as favorable or unfavorable to each procedure. 
Also, it is important to recognize and understand lim-
itations of published evidence regarding which surgi-
cal treatment option is better than the other.
GSH PROTOCOL FOR CAROTID ARTERY STENOSIS
102  J Cerebrovasc Endovasc Neurosurg
Yet, no guidelines have been established for decid-
ing on a proper surgical treatment option between 
CEA and CAS according to the benefits and risks of 
each procedure in institutions where both CEA and 
CAS are available. Thus, we propose a protocol for 
selection of a proper surgical treatment option for car-
otid artery stenosis.
MATERIALS AND METHODS
Eligibility for surgical treatment
A multidisciplinary team including neurosurgeons, 
neurologists, and radiologists participated in develop-
ment of a protocol for selection of a proper surgical 
treatment option. Indications for surgical treatment 
(CEA or CAS) of patients with carotid artery stenosis 
were decided according to three international guide-
lines, the European Union Stroke Initiative clinical 
guidelines, the North American Symptomatic Carotid 
Endarterectomy Trial criteria, and the American Stroke 
association, with high level of evidence.4)10)25)30)32) 
Patients satisfying the indications were considered for 
the treatment.
Search strategy and making a protocol
A search for systematic literature review was per-
formed using the key words "Carotid artery stenosis" 
or "Carotid endarterectomy" or "Carotid artery stent-
ing" or "Carotid stenting versus endarterectomy" on 
PubMed and Medline. A total of 192 published ar-
ticles written in English were selected and were re-
viewed independently by three authors. Among the 
192 articles, 28 articles were selected as references for 
this study and they all met following criteria: 1) sin-
gle or multiple randomized clinical trials, 2) review 
articles in journals with high impact factors (≥ 6), or 
3) well-designed case-control studies including a large 
number of patients.
From those articles, we selected preoperatively con-
siderable factors which had been repeatedly noted in 
several chosen articles for risk/benefits of CEA or 
CAS.7)9)18)19)23)29)31)32)35)38)50) According to those factors, 
we made a general outline of our protocol. Then, we 
descended to particulars in order to specify exact in-
dicative values for each factor suitable for our institution. 
Preoperative evaluation
Preoperatively, clinical evaluation was performed 
for the neurological assessment including the National 
Institutes of Health Stroke Scale.28) Radiographic eval-
uation was also performed, such as carotid artery 
computed tomography (CT), magnetic resonance an-
giography (MRA), and digital subtraction cerebral an-
giography (DSA). Routine echocardiogram was also 
performed for evaluation of cardiac function and pos-
sible sources of embolus.
RESULTS
This protocol was designed for mainly elective cases 
and was focused on the patient with a symptomatic 
carotid artery stenosis ≥ 50%, an asymptomatic steno-
sis ≥ 80%, or an asymptomatic stenosis ≥ 50% with 
contralateral carotid artery occlusion. Emergent cases, 
such as acute ischemic stroke due to or combined 
with carotid artery stenosis, as well as strong prefer-
ence of patients for a certain treatment option were 
considered as an exceptional situation.
We have established a protocol with four categories 
based on the selected factors, which were difficulties 
of anatomic approach to the carotid artery either by 
CEA or CAS, cardiopulmonary function (evaluated by 
echocardiogram and pulmonary function test), existence 
of renal failure, a previous history of neck treatment 
(neck surgery or radiation), contralateral laryngeal pa-
ralysis, allergic reaction to contrast medium, vascular 
access for diagnostic DSA, calcification around the 
carotid artery stenosis (evaluated by carotid artery CT), 
complicated atheroma on the ascending aortic arch 
(evaluated by echocardiogram), string sign, ulcerated 
stenosis (evaluated by DSA when it was seen as a cra-
ter from the lumen into a stenotic plaque), the length 
of the lesion, and the existence of tandem stenosis 
(multifocal stenosis from the proximal cervical to the 
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Absolute CAS Favorable CAS Favorable CEA Absolute CEA
Heart failure
(TEE, ejection fraction ≤ 30%)
Stable angina including a history 
of coronary stenting with
30% < ejection fraction ≤ 40%
Renal failure without 
hemodialysis Failure of DSA
Myocardial infarction
within 4 weeks
Poor collateral flow of anterior 
communicating artery
Complicated atheroma
on the ascending aortic arch
Severe vascular disease of
femoral access
Need for open heart surgery
within 6 weeks Carotid artery tandem lesions Type 3 aortic arch Allergic reaction to contrast
Pulmonary dysfunction
(PFT, FEV1 or DLCO ≤ 50%) Emergency String sign
Heavy calcification:
concentric circumferential ≥270°
Contralateral carotid artery 
occlusion Ulcerated lesion
Contralateral laryngeal paralysis The length of the lesion ≥ 30 mm
High stenosis above C2 or
low stenosis below clavicle
Thrombus-containing stenosis on 
DSA
Previous radiation of the neck
Moderate calcification
(90° ≤ circumference < 270°)
with calcification thickness 
≥ 3 mm
Previous radical neck surgery
Restenosis after CEA
Former tracheostomy
CAS = carotid artery stenting; CEA = carotid endarterectomy; TEE = transesophageal echocardiogram; DSA = digital subtraction cerebral 
angiography; PFT = pulmonary function test; FEV1 = forced expiratory volume in 1 second; DLCO = diffusion capacity of the lung for 
carbon monoxide
Table 1. Protocol for selection of a proper surgical treatment option for carotid artery stenosis
distal internal carotid artery or to the ipsilateral mid-
dle cerebral artery), contralateral carotid artery occlu-
sion, and poor collateral flow of the anterior commu-
nicating artery.5)6)11)12)14-17)20)22-24)26)27)31)33)34)40-43)46)48)49)
Table 1 shows our protocol for selection of a proper 
surgical treatment option for carotid artery stenosis. 
Each treatment option (CEA or CAS) had absolute 
and favorable indications. A simple numerical score 
was assigned for those indications. We granted the 
weight to the absolute indications three times rather 
than the favorable indications because the absolute in-
dications have been debated in several articles includ-
ing major randomized controlled trials and were con-
sidered as "absolute." Thus, we discussed and decided 
that one absolute indication should be considered 
more important than two favorable indications. 
Therefore, each absolute indication was scored with 
three points, and each favorable indication, one point. 
Based on the highest scores, a proper treatment op-
tion (CEA or CAS) can be selected. If the score was 
the same, patient preference would be a key to se-
lection of a treatment option.
Absolute indications for CEA
CEA is chosen over CAS in cases of failed DSA,12) 
severe vascular disease of femoral access,27) allergic 
reaction to contrast,26) or heavy calcification around 
the carotid stenosis with a concentric circumference ≥ 
270 degrees.12)20)26)27)38)40) 
Favorable indications for CEA
CEA may be chosen over CAS in cases of renal failure 
without hemodialysis,34)46) complicated atheroma on the 
ascending aortic arch,11)23) type 3 aortic arch, the string 
sign,21)24) thrombus-containing lesion on DSA,21)23) pres-
ence of ulcerated lesions,16)22) the length of the lesion 
≥ 30 mm,14)17)42)49) or moderate calcification around the 
carotid stenosis with a circumference between 90 and 
270 degrees with maximal thickness of calcified pla-
que ≥ 3 mm.20)39)41)
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Absolute indications for CAS
CAS is chosen over CEA in cases of heart failure (e-
jection fracture ≤ 30%),5)31)41)44) myocardial infarction 
within 4 weeks,5)31)33) need for open heart surgery within 
6 weeks,5)31)40) pulmonary dysfunction (forced expiratory 
volume in 1 second or diffusion capacity for carbon 
monoxide ≤ 50%),31) contralateral carotid artery occlusion, 
contralateral laryngeal paralysis, high stenosis above 
the C2 body, low stenosis below the clavicle, previous 
radiation of the neck, previous radical neck surgery, 
restenosis after CEA, or former tracheostomy.6)48)
Favorable indications for CAS
CAS may be chosen over CEA in cases of stable an-
gina including a history of coronary stenting with 
ejection fraction between 30% and 40%,5)31)40)44) poor 
collateral flow of the anterior communicating artery,40) 
carotid artery tandem lesions,49) or in emergent cases, 
such as thrombolysis or thrombectomy in patients 
with acute ischemic stroke due to or combined with 
carotid artery stenosis.
DISCUSSION
By reviewing recent evidence, we understood that 
the risk of periprocedural stroke was lower for CEA 
than CAS in symptomatic patients and octogenarians. 
In addition, more data from long-term follow-up was 
available for CEA than CAS. However, CEA showed 
higher risk of periprocedural myocardial infarction, 
cranial nerve damage, and wound complications than 
CAS. Also, in most cases CEA required general anes-
thesia and a longer recovery period than CAS.
After understanding those concepts from recent evi-
dence, we proposed a protocol for selection of a prop-
er surgical treatment option for carotid artery stenosis 
according to various factors which had been noted in 
several articles including the major randomized con-
trolled trials. If the procedure of CEA or CAS became 
complicated, procedure-related complications could 
increase and clinical outcomes would be poor. Thus, 
we would like to develop a scoring system for assess-
ment of risk/benefit of CEA or CAS. And, we ex-
pected that this protocol might be helpful for assess-
ment of risk/benefit for selection of a proper surgical 
treatment option in the future. We have been evaluat-
ing the outcomes and complications of our proto-
col-based decision.
This protocol was designed for mainly elective cases 
and we usually performed CEA or CAS within 14 
days of acute stroke events in patients with sympto-
matic lesions.9) Previously, early treatment within two 
weeks of acute stroke could increase the risk of the 
treatment.3) However, recent analysis showed that de-
layed surgery after 2 weeks of acute stroke events did 
not reduce the risk of the treatment but increased the 
risk of recurrent events of stroke.38) In addition, the 
surgical treatment was safe and most effective when 
performed within 2 weeks of the patient's last 
symptoms.1)8)36)37) Patient's age was not included in 
this protocol. Stroke guidelines recommended that it 
is reasonable to consider patient age in choosing be-
tween CAS and CEA. For older patients (octogenarians), 
CEA may be associated with improved outcome com-
pared with CAS, particularly when arterial anatomy 
is unfavorable for endovascular intervention.9) In ad-
dition, the Carotid Revascularization Endarterectomy 
versus Stenting Trial (CREST) investigators showed 
that younger patients had relatively lower risk of 
stroke and older patients had higher relative stroke 
risk in the CAS group than in the CEA group.45) 
However, after discussing patient age, we decided to 
ignore patient age and to consider individual physical 
capability. We thought that age itself did not affect 
the risk/benefit of CEA or CAS, but age-related co-
morbidities, such as cardiopulmonary problems, un-
favorable vascular anatomy, or characteristics of stenosis, 
did affect the risk/benefit. Thus, we included those 
comorbidities in our protocol rather than patient age.
In our institution, CEA has been performed under 
general anesthesia. Because cardiopulmonary dysfunc-
tion is a possible risk factor of general anesthesia, it 
can work against CEA. In addition, death due to car-
diac origin is a well-known disadvantage of CEA. 
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Thus, we included cardiopulmonary dysfunction as 
an indication for CAS. Patients with a history of coro-
nary artery disease had a 6.5-fold increased rate of 
postoperative non Q-wave myocardial infarction.31) 
Also, there is a 3-fold higher risk of ipsilateral stroke 
in patients with myocardial infarction, congestive 
heart failure, atrial fibrillation, left ventricular hyper-
trophy, and oxygen dependent pulmonary disease 
compared to those without such medical risk 
factors.31)33)40) Patients with stable angina including a 
history of coronary stenting with ejection fraction be-
tween 30% and 40% were at risk of postoperative is-
chemic attack.31)
We preferred CEA for calcified stenosis because cal-
cification around the carotid artery stenosis was an 
important predictor of complications of CAS in several 
studies.20)39)41) Heavy calcification in combination with 
arterial tortuosity caused difficulties in stent position-
ing, lesion dilatation, and adequate stent expansion.39) 
This might be related to new post-procedural ischemic 
injuries.20)39)41) Thus, we included calcification around 
the stenosis as an indication for CEA.
Potential embolic sources during the procedure of 
CAS, such as atherosclerotic aortic lesions, the string 
sign, or the presence of ulcerated lesions, were cate-
gorized to favorable indications for CEA. These fac-
tors could be associated with thromboembolic events 
with a high incidence of ischemic complications dur-
ing CAS and make CAS complicated.7)11)13)16)18)21)22)24) 
In addition, the length of the lesion ≥ 30 mm required 
the use of longer stents of multiple stents,17)49) which 
could increase the technical complexity of CAS and 
result in poor clinical outcomes. Patients with renal 
failure without hemodialysis were considered for 
CEA because nephrotoxicity induced by contrast me-
dium was associated with the potential need for renal 
replacement therapy and increased mortality.47) If pa-
tients with end stage renal disease underwent dialy-
sis, CAS could be performed without concern for con-
trast-induced nephropathy.
CONCLUSION
We have been treating the patients according to this 
protocol and evaluating the outcomes of our proto-
col-based decision because this protocol might be 
helpful in assessment of risk/benefit for selection of a 
proper surgical treatment option in patients with car-
otid artery stenosis. Our results with short- and 
long-term follow-ups will be reported.
Disclosure
The authors report no conflict of interest concerning 
materials or methods used in this study.
REFERENCES
1. Aleksic M, Rueger MA, Lehnhardt FG, Sobesky J, 
Matoussevitch V, Neveling M, et al. Primary stroke unit 
treatment followed by very early carotid endarterectomy 
for carotid artery stenosis after acute stroke. Cerebrovasc 
Dis. 2006 Aug;22(4):276-81.
2. Blackshear JL, Cutlip DE, Roubin GS, Hill MD, 
Leimgruber PP, Begg RJ, et al. Myocardial infarction af-
ter carotid stenting and endarterectomy: results from the 
carotid revascularization endarterectomy versus stenting 
trial. Circulation. 2011 Jun;123(22):2571-8.
3. Bond R, Rerkasem K, Rothwell PM. Systematic review 
of the risks of carotid endarterectomy in relation to the 
clinical indication for and timing of surgery. Stroke. 
2003 Sep;34(9):2290-301.
4. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, 
Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR 
/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on 
the management of patients with extracranial carotid and 
vertebral artery disease: executive summary: a report of 
the American College of Cardiology Foundation/American 
Heart Association Task Force on Practice Guidelines, and 
the American Stroke Association, American Association of 
Neuroscience Nurses, American Association of Neurological 
Surgeons, American College of Radiology, American Society 
of Neuroradiology, Congress of Neurological Surgeons, 
Society of Atherosclerosis Imaging and Prevention, Society 
for Cardiovascular Angiography and Interventions, Society 
of Interventional Radiology, Society of NeuroInterventional 
Surgery, Society for Vascular Medicine, and Society for 
Vascular Surgery. Vasc Med. 2011 Feb;16(1):35-77.
5. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, 
Clark WM, Brooks W, et al. Stenting versus endarter-
ectomy for treatment of carotid-artery stenosis. N Engl J 
Med. 2010 Jul;363(1):11-23.
6. Burgazli KM, Bilgin M, Kavukcu E, Mericliler M, Bohl 
N, Atmaca N. Which is a better treatment for carotid 
artery stenosis: stenting or endarterectomy? Eur Rev 
Med Pharmacol Sci. 2013 Apr;17(8):1025-32. 
GSH PROTOCOL FOR CAROTID ARTERY STENOSIS
106  J Cerebrovasc Endovasc Neurosurg
7. CAVATAS investigators. Endovascular versus surgical 
treatment in patients with carotid stenosis in the 
Carotid and Vertebral Artery Transluminal Angioplasty 
Study (CAVATAS): a randomised trial. Lancet. 2001 
Jun;357(9270):1729-37.
8. Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente 
O, Cohen SN, et al. Carotid endarterectomy--an evi-
dence-based review: report of the Therapeutics and 
Technology Assessment Subcommittee of the American 
Academy of Neurology. Neurology. 2005 Sep;65(6):794-801. 
9. European Carotid Surgery Trialists' Collaborative Group. 
Randomized trial of endarterectomy for recently sympto-
matic carotid stenosis: final results of the MRC European 
Carotid Surgery Trial (ECST). Lancet. 1998 May;351(9113) 
:1379-87.
10. European Stroke Initiative Executive Committee; EUSI 
Writing Committee, Olsen TS, Langhorne P, Diener HC, 
Hennerici M, et al. European Stroke Initiative 
Recommendations for Stroke Management-update 2003. 
Cerebrovasc Dis. 2003;16(4):311-37.
11. Faggioli G, Ferri M, Rapezzi C, Tonon C, Manzoli L, 
Stella A. Atherosclerotic aortic lesions increase the risk 
of cerebral embolism during carotid stenting in patients 
with complex aortic arch anatomy. J Vasc Surg. 2009 
Jan;49(1):80-5.
12. Faggioli GL, Ferri M, Freyrie A, Gargiulo M, Fratesi F, 
Rossi C, et al. Aortic arch anomalies are associated with 
increased risk of neurological events in carotid stent 
procedures. Eur J Vasc Endovasc Surg. 2007 Apr;33(4):436-41.
13. Goldstein LB, McCrory DC, Landsman PB, Samsa GP, 
Ancukiewicz M, Oddone EZ, et al. Multicenter review 
of preoperative risk factors for carotid endarterectomy in 
patients with ipsilateral symptoms. Stroke. 1994 Jun;25(6) 
:1116-21.
14. Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, 
Wholey M, et al. The CAPTURE registry: predictors of 
outcomes in carotid artery stenting with embolic pro-
tection for high surgical risk patients in the early 
post-approval setting. Catheter Cardiovasc Interv. 2007 
Dec;70(7):1025-33.
15. Gribar JJ, Jiddou M, Choksi N, Abbas AE, Bowers T, 
Kazmierczak C, et al. Carotid stenting in high-risk pa-
tients: early and late outcomes. J Interv Cardiol. 2011 
Jun;24(3):247-53.
16. Groschel K, Ernemann U, Schnaudigel S, Wasser K, 
Nagele T, Kastrup A. A risk score to predict ischemic 
lesions after protected carotid artery stenting. J Neurol 
Sci. 2008 Oct;273(1-2):112-5.
17. Groschel K, Schnaudigel S, Ernemann U, Wasser K, 
Kastrup A. Size matters! Stent-length is associated with 
thrombembolic complications after carotid artery stenting. 
Stroke. 2008 Aug;39(8):e131-2.
18. SPACE Collaborative Group, Ringleb PA, Allenberg J, 
Br?ckmann H, Eckstein HH, Fraedrich G, et al. 30 day 
results from the SPACE trial of stent-protected angio-
plasty versus carotid endarterectomy in symptomatic pa-
tients: a randomised non-inferiority trial. Lancet. 2006 
Oct;368(9543):1239-47.
19. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, 
Bajwa TK, et al. Long-term results of carotid stenting 
versus endarterectomy in high-risk patients. N Engl J 
Med. 2008 Apr;358(15):1572-9.
20. Hofmann R, Niessner A, Kypta A, Steinwender C, 
Kammler J, Kerschner K, et al. Risk score for peri-inter-
ventional complications of carotid artery stenting. Stroke. 
2006 Oct;37(10):2557-61.
21. Honda M, Kitagawa N, Tsutsumi K, Nagata I, Morikawa 
M, Hayashi T. High-resolution magnetic resonance imag-
ing for detection of carotid plaques. Neurosurgery. 2006 
Feb;58(2):338-46.
22. Horie N, Morikawa M, Ishizaka S, Takeshita T, So G, 
Hayashi K, et al. Assessment of carotid plaque stability 
based on the dynamic enhancement pattern in plaque 
components with multidetector CT angiography. Stroke. 
2012 Feb;43(2):393-8.
23. International Carotid Stenting Study investigators, Ederle 
J, Dobson J, Featherstone RL, Bonati LH, van der Worp 
HB, et al. Carotid artery stenting compared with endar-
terectomy in patients with symptomatic carotid stenosis 
(International Carotid Stenting Study): an interim analy-
sis of a randomised controlled trial. Lancet. 2010 
Mar;375(9719):985-97.
24. Kashyap VS, Clair DG. Carotid string sign. J Vasc Surg. 
2006 Feb;43(2):401.
25. Kernan WN, Ovbiagele B, Black HR, Bravata DM, 
Chimowitz MI, Ezekowitz MD, et al. Guideline for the 
Prevention of Stroke in Patients With Stroke and 
Transient Ischemic Attack: A Guideline for Healthcare 
Professionals From the American Heart Association/ 
American Stroke Association. Stroke. 2014 Jul;45(7):2160-236.
26. Ketkar M, Shrier D. An allergic reaction to intraarterial 
nonionic contrast material. AJNR Am J Neuroradiol. 
2003 Feb;24(2):292.
27. Lam RC, Lin SC, DeRubertis B, Hynecek R, Kent KC, 
Faries PL. The impact of increasing age on anatomic 
factors affecting carotid angioplasty and stenting. J Vasc 
Surg. 2007 May;45(5):875-80.
28. Lyden P, Raman R, Liu L, Emr M, Warren M, Marler J. 
National Institutes of Health Stroke Scale certification is 
reliable across multiple venues. Stroke 2009 Jul;40(7):2507-11.
29. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin 
T, Becquemin JP, et al. Endarterectomy versus stenting 
in patients with symptomatic severe carotid stenosis. N 
Engl J Med. 2006 Oct;355(16):1660-71.
30. Meschia JF, Bushnell C, Boden-Albala B, Braun LT, 
Bravata DM, Chaturvedi S, et al. Guideline for the primary 
prevention of stroke: a statement for healthcare pro-
fessionals from the American Heart Association/American 
Stroke Association. Stroke. 2014 Dec;45(12):3754-832.
31. Mozes G, Sullivan TM, Torres-Russotto DR, Bower TC, 
Hoskin TL, Sampaio SM, et al. Carotid endarterectomy 
in SAPPHIRE-eligible high-risk patients: implications for 
selecting patients for carotid angioplasty and stenting. J 
Vasc Surg. 2004 May;39(5):958-65; discussion 965-6.
32. North American Symptomatic Carotid Endarterectomy 
Trial Collaborators. Beneficial effect of carotid endarter-
ectomy in symptomatic patients with high-grade carotid 
stenosis. N Engl J Med. 1991 Aug;325(7):445-53.
33. Ogata T, Inoue T, Okada Y. Outcome of 312 Japanese 
patients with carotid endarterectomy and factors asso-
 E-WOOK JANG ET AL
Volume 17 · Number 2 · June 2015  107
ciated with cardiovascular events-a single-center study in 
Japan. J Stroke Cerebrovasc Dis. 2014 Mar;23(3):529-33.
34. Okawa M, Ueba T, Ogata T, Abe H, Higashi T, Inoue 
T. Long-term morbidity and mortality of carotid endar-
terectomy in patients with end-stage renal disease re-
ceiving hemodialysis. J Stroke Cerebrovasc Dis. 2014 
Mar;23(3):545-9.
35. Paraskevas KI, Mikhailidis DP, Liapis CD, Veith FJ. 
Critique of the Carotid Revascularization Endarterectomy 
versus Stenting Trial (CREST): flaws in CREST and its 
interpretation. Eur J Vasc Endovasc Surg. 2013 Jun;45(6) 
:539-45.
36. Paty PS, Darling RC 3rd, Feustel PJ, Bernardini GL, 
Mehta M, Ozsvath KJ, et al. Early carotid endarterectomy 
after acute stroke. J Vasc Surg. 2004 Jan;39(1):148-54.
37. Rantner B, Pavelka M, Posch L, Schmidauer C, Fraedrich 
G. Carotid endarterectomy after ischemic stroke--is there 
a justification for delayed surgery? Eur J Vasc Endovasc 
Surg. 2005 Jul;30(1):36-40.
38. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, 
Barnett HJ; Carotid Endarterectomy Trialists Collaboration. 
Endarterectomy for symptomatic carotid stenosis in rela-
tion to clinical subgroups and timing of surgery. Lancet. 
2004 Mar;363(9413):915-24.
39. Roubin GS, Iyer S, Halkin A, Vitek J, Brennan C. 
Realizing the potential of carotid artery stenting: pro-
posed paradigms for patient selection and procedural 
technique. Circulation. 2006 Apr;113(16):2021-30.
40. Safian RD. Treatment strategies for carotid stenosis in 
patients at increased risk for surgery. Prog Cardiovasc 
Dis. 2011 Jul-Aug;54(1):22-8.
41. Setacci C, Chisci E, Setacci F, Iacoponi F, de Donato G, Rossi 
A. Siena carotid artery stenting score: a risk modelling 
study for individual patients. Stroke. 2010 Jun;41(6):1259-65.
42. Shankar JJ, Zhang J, dos Santos M, Lesiuk H, Mohan R, 
Lum C. Factors affecting long-term restenosis after carotid 
stenting for carotid atherosclerotic disease. Neuroradiology. 
2012 Dec;54(12):1347-53.
43. Streifler JY, Eliasziw M, Fox AJ, Benavente OR, 
Hachinski VC, Ferguson GG, et al. Angiographic de-
tection of carotid plaque ulceration. Comparison with 
surgical observations in a multicenter study. North 
American Symptomatic Carotid Endarterectomy Trial. 
Stroke. 1994 Jun;25(6):1130-2.
44. Veith FJ, Paraskevas KI. Influence and critique of CREST 
and ICSS Trials. Semin Vasc Surg. 2011 Sep;24(3):153-6.
45. Voeks JH, Howard G, Roubin GS, Malas MB, Cohen DJ, 
Sternbergh WC 3rd, et al. Age and outcomes after car-
otid stenting and endarterectomy: the carotid revascula-
rization endarterectomy versus stenting trial. Stroke. 
2011 Dec;42(12):3484-90.
46. Vouyouka AG, Egorova NN, Sosunov EA, Moskowitz 
AJ, Gelijns A, Marin M, et al. Analysis of Florida and 
New York state hospital discharges suggests that carotid 
stenting in symptomatic women is associated with sig-
nificant increase in mortality and perioperative morbid-
ity compared with carotid endarterectomy. J Vasc Surg. 
2012 Aug;56(2):334-42.
47. Weisbord SD, Palevsky PM. Radiocontrast-induced acute 
renal failure. J Intensive Care Med. 2005 Mar-Apr;20(2) 
:63-75.
48. White CJ, Ramee SR, Collins TJ, Jenkins JS, Reilly JP, Patel 
RA. Carotid artery stenting: Patient, lesion, and procedural 
characteristics that increase procedural complications. 
Catheter Cardiovasc Interv. 2013 Nov;82(5):715-26.
49. Wimmer NJ, Yeh RW, Cutlip DE, Mauri L. Risk pre-
diction for adverse events after carotid artery stenting in 
higher surgical risk patients. Stroke. 2012 Dec;43(12):3218-24.
50. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, 
Mishkel GJ, et al. Protected carotid-artery stenting ver-
sus endarterectomy in high-risk patients. N Engl J Med. 
2004 Oct;351(15):1493-501.
